42 related articles for article (PubMed ID: 24771267)
1. Serum transforming growth factor-beta 1 (TGF-β1) levels have diagnostic, predictive, and possible prognostic roles in patients with melanoma.
Tas F; Karabulut S; Yasasever CT; Duranyildiz D
Tumour Biol; 2014 Jul; 35(7):7233-7. PubMed ID: 24771267
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor β-1 (TGF-β1) is a serum biomarker of radiation induced fibrosis in patients treated with intracavitary accelerated partial breast irradiation: preliminary results of a prospective study.
Boothe DL; Coplowitz S; Greenwood E; Barney CL; Christos PJ; Parashar B; Nori D; Chao KS; Wernicke AG
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1030-6. PubMed ID: 24139518
[TBL] [Abstract][Full Text] [Related]
3. TGF beta and IL13 in Schistosomiasis mansoni associated pulmonary arterial hypertension; a descriptive study with comparative groups.
Ferreira Rde C; Montenegro SM; Domingues AL; Bandeira AP; Silveira CA; Leite LA; Pereira Cde A; Fernandes IM; Mertens AB; Almeida MO
BMC Infect Dis; 2014 May; 14():282. PubMed ID: 24886277
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor beta 1 (TGF-β1) in COVID-19 patients: relation to platelets and association with the disease outcome.
Zivancevic-Simonovic S; Minic R; Cupurdija V; Stanojevic-Pirkovic M; Milosevic-Djordjevic O; Jakovljevic V; Mihaljevic O
Mol Cell Biochem; 2023 Nov; 478(11):2461-2471. PubMed ID: 36869188
[TBL] [Abstract][Full Text] [Related]
5. Serum transforming growth factor-beta 1 is related to the degree of immunoparesis in patients with multiple myeloma.
Kyrtsonis MC; Repa C; Dedoussis GV; Mouzaki A; Simeonidis A; Stamatelou M; Maniatis A
Med Oncol; 1998 Jul; 15(2):124-8. PubMed ID: 9789221
[TBL] [Abstract][Full Text] [Related]
6. Helper Innate Lymphoid Cells-Unappreciated Players in Melanoma Therapy.
Garofalo C; Cerantonio A; Muscoli C; Mollace V; Viglietto G; De Marco C; Cristiani CM
Cancers (Basel); 2023 Feb; 15(3):. PubMed ID: 36765891
[TBL] [Abstract][Full Text] [Related]
7. Serum Levels of Transforming Growth Factor Beta 1 in Systemic Lupus Erythematosus Patients.
Gómez-Bernal F; Quevedo-Abeledo JC; García-González M; Fernández-Cladera Y; González-Rivero AF; de Vera-González A; Martín-González C; González-Gay MÁ; Ferraz-Amaro I
Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671458
[TBL] [Abstract][Full Text] [Related]
8. Targeting transforming growth factor-β2 by antisense oligodeoxynucleotide accelerates T cell-mediated tumor rejection in a humanized mouse model of triple-negative breast cancer.
Lee HK; Ji HJ; Shin SK; Koo J; Kim TH; Kim CW; Seong YH; Park JE; Choi KC
Cancer Immunol Immunother; 2022 Sep; 71(9):2213-2226. PubMed ID: 35099588
[TBL] [Abstract][Full Text] [Related]
9. TGFβ drives NK cell metabolic dysfunction in human metastatic breast cancer.
Slattery K; Woods E; Zaiatz-Bittencourt V; Marks S; Chew S; Conroy M; Goggin C; MacEochagain C; Kennedy J; Lucas S; Finlay DK; Gardiner CM
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33568351
[TBL] [Abstract][Full Text] [Related]
10. Innate Lymphoid Cells in the Malignant Melanoma Microenvironment.
Apraiz A; Benedicto A; Marquez J; Agüera-Lorente A; Asumendi A; Olaso E; Arteta B
Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33138017
[TBL] [Abstract][Full Text] [Related]
11. Obesity attenuates the effect of sleep apnea on active TGF-ß1 levels and tumor aggressiveness in patients with melanoma.
Cubillos-Zapata C; Martínez-García MÁ; Díaz-García E; Jaureguizar A; Campos-Rodríguez F; Sánchez-de-la-Torre M; Nagore E; Martorell-Calatayud A; Blasco LH; Pastor E; Abad-Capa J; Montserrat JM; Cabriada-Nuño V; Cano-Pumarega I; Corral-Peñafiel J; Arias E; Mediano O; Somoza-González M; Dalmau-Arias J; Almendros I; Farré R; López-Collazo E; Gozal D; García-Río F
Sci Rep; 2020 Sep; 10(1):15528. PubMed ID: 32968152
[TBL] [Abstract][Full Text] [Related]
12. TGFβ-Directed Therapeutics: 2020.
Teicher BA
Pharmacol Ther; 2021 Jan; 217():107666. PubMed ID: 32835827
[TBL] [Abstract][Full Text] [Related]
13. "To Anticipate": Neoadjuvant Therapy in Melanoma with a Focus on Predictive Biomarkers.
Garutti M; Buriolla S; Bertoli E; Vitale MG; Rossi E; Schinzari G; Minisini AM; Puglisi F
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32708968
[TBL] [Abstract][Full Text] [Related]
14. Inflammation markers in cutaneous melanoma - edgy biomarkers for prognosis.
Neagu M; Constantin C; Dumitrascu GR; Lupu AR; Caruntu C; Boda D; Zurac S
Discoveries (Craiova); 2015 Mar; 3(1):e38. PubMed ID: 32309563
[TBL] [Abstract][Full Text] [Related]
15. High-Throughput, Temporal and Dose Dependent, Effect of Vitamins and Minerals on Chondrogenesis.
Dennis JE; Splawn T; Kean TJ
Front Cell Dev Biol; 2020; 8():92. PubMed ID: 32161755
[TBL] [Abstract][Full Text] [Related]
16. FOXP3 expression is modulated by TGF‑β1/NOTCH1 pathway in human melanoma.
Skarmoutsou E; Bevelacqua V; D' Amico F; Russo A; Spandidos DA; Scalisi A; Malaponte G; Guarneri C
Int J Mol Med; 2018 Jul; 42(1):392-404. PubMed ID: 29620159
[TBL] [Abstract][Full Text] [Related]
17. UV radiation promotes melanoma dissemination mediated by the sequential reaction axis of cathepsins-TGF-β1-FAP-α.
Wäster P; Orfanidis K; Eriksson I; Rosdahl I; Seifert O; Öllinger K
Br J Cancer; 2017 Aug; 117(4):535-544. PubMed ID: 28697174
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of sphingosine kinase-1 induces protective tumor immunity by promoting M1 macrophage response in melanoma.
Mrad M; Imbert C; Garcia V; Rambow F; Therville N; Carpentier S; Ségui B; Levade T; Azar R; Marine JC; Diab-Assaf M; Colacios C; Andrieu-Abadie N
Oncotarget; 2016 Nov; 7(44):71873-71886. PubMed ID: 27708249
[TBL] [Abstract][Full Text] [Related]
19. Clinical and prognostic significance of serum transforming growth factor-beta1 levels in patients with pancreatic ductal adenocarcinoma.
Zhao J; Liang Y; Yin Q; Liu S; Wang Q; Tang Y; Cao C
Braz J Med Biol Res; 2016 Jul; 49(8):. PubMed ID: 27464025
[TBL] [Abstract][Full Text] [Related]
20. Correlation of TGF-β1 and oxidative stress in the blood of patients with melanoma: a clue to understanding melanoma progression?
Santos Bernardes S; de Souza-Neto FP; Pasqual Melo G; Guarnier FA; Marinello PC; Cecchini R; Cecchini AL
Tumour Biol; 2016 Aug; 37(8):10753-61. PubMed ID: 26873487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
